de Bakker Jacob, Biesma Hedde, Soeratram Tanya, Egthuijsen Jacqueline, de Back Tim, Besselink Marc, Vermeulen Louis, Ylstra Bauke, van Grieken Nicole, Kazemier Geert
Department of Surgery, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, the Netherlands.
Cancer Center Amsterdam, Amsterdam, the Netherlands.
Genes Chromosomes Cancer. 2025 Jul;64(7):e70061. doi: 10.1002/gcc.70061.
The molecular and histological characteristics of primary duodenal adenocarcinoma (DA) have been poorly described, which hampers the development of new treatment options. This study aimed to characterize the landscape of chromosomal copy number aberrations (CNAs), microsatellite instability status, and tumor-stroma content, and their association with clinicopathological characteristics of patients with DA.
DNA was extracted from tumor tissues of patients who underwent a primary surgical resection for DA in a single center (2000-2019). Shallow whole genome sequencing (sWGS) was performed to identify chromosomal CNAs and the genomic instability index (GII), for which 25% of the genome was altered, was used to classify tumors as CNA or CNA. A PCR-based assay was performed to classify tumors as microsatellite stable (MSS) or instable (MSI). Immunohistochemistry and digital image analysis were performed to determine the tumor-stroma content, for which 50% stroma content was used to classify tumors as stroma or stroma.
Among 74 patients with resected DA, sWGS identified 39 (52.7%) CNA and 35 (47.3%) CNA tumors. Overall, 16 (21.6%) DAs were MSI. All MSI tumors were CNA. The tumor-stroma content was low in 51 (68.9%) and high in 23 (31.1%) of DAs. CNA status was most predictive for 5-year overall survival: 45.5% for patients with CNA compared to 31.0% for patients with CNA DA (HR 2.20, 95% CI 1.12-4.30, p = 0.02).
About half of resected DAs had CNA, which was associated with the most favorable prognosis. Subgrouping of DA could be used for patient stratification in future trials testing novel therapies.
原发性十二指肠腺癌(DA)的分子和组织学特征描述较少,这阻碍了新治疗方案的开发。本研究旨在描述染色体拷贝数变异(CNA)、微卫星不稳定性状态和肿瘤-基质含量的情况,以及它们与DA患者临床病理特征的关联。
从在单一中心接受DA初次手术切除的患者的肿瘤组织中提取DNA(2000 - 2019年)。进行浅层全基因组测序(sWGS)以识别染色体CNA,并使用基因组不稳定性指数(GII)(基因组的25%发生改变)将肿瘤分类为CNA或CNA。进行基于聚合酶链反应的检测以将肿瘤分类为微卫星稳定(MSS)或不稳定(MSI)。进行免疫组织化学和数字图像分析以确定肿瘤-基质含量,使用50%的基质含量将肿瘤分类为基质丰富或基质缺乏。
在74例接受手术切除的DA患者中,sWGS识别出39例(52.7%)CNA肿瘤和35例(47.3%)非CNA肿瘤。总体而言,16例(21.6%)DA为MSI。所有MSI肿瘤均为CNA。51例(68.9%)DA的肿瘤-基质含量低,23例(31.1%)DA的肿瘤-基质含量高。CNA状态对5年总生存率的预测性最强:CNA患者为45.5%,而非CNA DA患者为31.0%(风险比2.20,95%置信区间1.12 - 4.30,p = 0.02)。
约一半接受手术切除的DA有CNA,这与最有利的预后相关。在未来测试新疗法的试验中,DA的亚组分类可用于患者分层。